MedPath

Larin 1.5/30

LARIN™ 1.5/30(Norethindrone Acetate and Ethinyl Estradiol Tablets, USP)

Approved
Approval ID

e232ed29-e6f5-4591-8d61-68eb8b1596f0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 26, 2023

Manufacturers
FDA

Northstar Rx LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate/Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16714-407
Application NumberANDA202996
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate/Ethinyl Estradiol
Product Specifications
Effective DateDecember 5, 2017
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Larin 1.5/30 - FDA Drug Approval Details